Navigation Links
Wisconsin VCs draw Missouri biotech firm to state

The Milwaukee County Research Park Center. ZyStor will have labs at the research park.
An investment of $8.5 million from a venture-capital syndicate has drawn a St. Louis niche-market biotech company to Wisconsin, where it will inhabit brand-new lab facilities at Milwaukee County Research Park.

The ......

Full article >>> CEO Loren G. Peterson said. Peterson, Chief Scientific Officer Jonathan H. LeBowitz and another senior scientist are moving to Wisconsin, where they expect to hire about 7 people over the next six months. Broderick said the company might employ as many as 20 in a few years.

The venture group, in addition to Mason Wells, includes Ve......

Full article >>> nzyme is the 800-pound gorilla in the space, said Chris Raymond, an analyst with Robert W. Baird & Co. Inc. Its 12-year-old drug for Gauchers disease, a better-known lysosomal condition, pulls in about $800 million a year, he said. Thats because the cost of a years treatment is about $160,000.

Pompe disease is newer and not as well under......

Full article >>> esearch Park edged it out on factors such as proximity to the Medical College of Wisconsin, Broderick said.

The two communities are close enough that there are still opportunities to be part of the synergy of Madisons life sciences, Arida said.

-----
Jason Stitt is WTNs associate editor and can be reached at

Source:wistechnology.com By Jason Stitt 11/05/04


Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
9. Legislature should look to Wisconsins natural energy advantages
10. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
11. BIO 2007: Wisconsin makes its presence felt
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners has ... pioneering medical device for the treatment of Age-Related Macular Degeneration. , The company’s ... global regulatory consultancy that helps companies like ours secure government approvals for their ...
(Date:1/21/2017)... 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... Company in North America 2016. ... based on the FDA approval of three innovative ... ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... how current market conditions have influenced the most recent ... Regulus Therapeutics Inc. (NASDAQ: RGLS ), Abeona ... Inc. (NASDAQ: TBPH ), and Sage Therapeutics ... new research report by Grand View Research, global Biotech market size ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... Technologies, announced today the next evolution in spinal fusion, the MISquito Percutaneous ... contrast to the competition, SpineFrontier is focused on technique driven product solutions ...
Breaking Biology Technology:
(Date:12/16/2016)... , Dec. 16, 2016   IdentyTechSolutions America ... management products and solutions and a cutting-edge manufacturer ... that it is offering seamless, integrated solutions that ... entrance products. The solutions provide IdentyTech,s customers with ... their facilities from crime and theft. ...
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):